Arcus Biosciences Stock Options Expiring on 21st of February

RCUS Stock  USD 14.87  0.19  1.26%   
Arcus Biosciences' latest option contracts expiring on February 21st 2025 are carrying combined implied volatility of 1.82. The Arcus Biosciences option chain provides detailed quote and price information for the current Arcus Biosciences option contracts. It shows all of Arcus Biosciences' listed puts, calls, expiration dates, strike prices, and other pricing information.

Arcus Biosciences In The Money Call Balance

When Arcus Biosciences' strike price is surpassing the current stock price, the option contract against Arcus Biosciences stock is said to be in the money. When it comes to buying Arcus Biosciences' options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' option contracts written on Arcus Biosciences are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.

Arcus Current Options Market Mood

Arcus Biosciences' open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Arcus Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.

Put-to-Call Volume

Unfortunately, most Arcus Biosciences' options investors are not very successful. Arcus Biosciences' option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction.

Rule 16 of the current Arcus contract

Base on the Rule 16, the options market is currently suggesting that Arcus Biosciences will have an average daily up or down price movement of about 0.11% per day over the life of the 2025-02-21 option contract. With Arcus Biosciences trading at USD 14.87, that is roughly USD 0.0169. If you think that the market is fully incorporating Arcus Biosciences' daily price movement you should consider buying Arcus Biosciences options at the current volatility level of 1.82%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
  

Arcus Biosciences Option Chain

When Arcus Biosciences' strike price is surpassing the current stock price, the option contract against Arcus Biosciences stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
Arcus Biosciences' option chain is a display of a range of information that helps investors for ways to trade options on Arcus. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Arcus. It also shows strike prices and maturity days for a Arcus Biosciences against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone.
Open IntStrike PriceCurrent SpreadLast Price
Call
RCUS250221C0000250002.510.5 - 15.210.5In
Call
RCUS250221C0000500005.08.1 - 12.98.1In
Call
RCUS250221C0000750007.55.6 - 10.55.6In
Call
RCUS250221C00010000010.03.6 - 7.93.6In
Call
RCUS250221C00012500012.51.5 - 6.11.5In
Call
RCUS250221C00015000015.00.15 - 5.00.15In
Call
RCUS250221C00017500017.50.0 - 4.84.8Out
Call
RCUS250221C00020000020.00.0 - 4.94.9Out
Call
RCUS250221C00022500022.50.0 - 4.94.9Out
Call
RCUS250221C00025000025.00.0 - 4.84.8Out
 Put
RCUS250221P0000250002.50.0 - 5.05.0Out
 Put
RCUS250221P0000500005.00.0 - 5.05.0Out
 Put
RCUS250221P0000750007.50.0 - 5.05.0Out
 Put
RCUS250221P00010000010.00.0 - 4.84.8Out
 Put
RCUS250221P00012500012.50.0 - 4.74.7Out
 Put
RCUS250221P00015000015.00.1 - 4.90.1Out
 Put
RCUS250221P00017500017.50.7 - 5.50.7In
 Put
RCUS250221P00020000020.02.9 - 7.52.9In
 Put
RCUS250221P00022500022.54.9 - 9.54.9In
 Put
RCUS250221P00025000025.07.7 - 11.67.7In

Arcus Total Stockholder Equity

Total Stockholder Equity

428.29 Million

At this time, Arcus Biosciences' Total Stockholder Equity is comparatively stable compared to the past year.

Arcus Biosciences Corporate Directors

Patrick MachadoIndependent DirectorProfile
Antoni RibasIndependent DirectorProfile
Andrew PerlmanIndependent DirectorProfile
Yasunori KanekoLead Independent DirectorProfile

Additional Tools for Arcus Stock Analysis

When running Arcus Biosciences' price analysis, check to measure Arcus Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arcus Biosciences is operating at the current time. Most of Arcus Biosciences' value examination focuses on studying past and present price action to predict the probability of Arcus Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Arcus Biosciences' price. Additionally, you may evaluate how the addition of Arcus Biosciences to your portfolios can decrease your overall portfolio volatility.